Promising efficacy and safety profiles were observed in prior Phase II studies in acute ischemic stroke patients treated with recanalization therapies. The ENIS-3 trial has achieved >33% of target ...
GNT Pharma Inc. today reported that the Korea Ministry of Food and Drug Safety (MFDS) has approved the Investigational New Drug Application (IND) for a phase III study of nelonemdaz for acute ischemic ...
** IND submitted to the FDA showing significantly improved patient condition when administered within 70 minutes of arrival at the Emergency Room ** *Multinational Phase 3 Clinical Trial protocols ...
MIERLO, THE NETHERLANDS – GNT by 2023 had reduced carbon intensity at its Exberry factories by 22% when compared to 2020, which puts the company nearly halfway to its goal of a 50% reduction by 2030, ...
Early last week the Financial Times published an article by Christopher Miller, its Ukrainian correspondent, covering the conflict between GNT Group, and their former creditors, Argentem Creek ...
MIERLO, THE NETHERLANDS — The GNT Group has launched Exberry sunshine shades, a collection of food colors that inspire “upbeat, positive” emotions, according to the company. The colors, which range ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback